Innoviva (NASDAQ: INVA) reported Q2 EPS of $0.02, $0.25 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $80.99 million versus the consensus estimate of $71.21 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.